(101 days)
Not Found
No
The summary describes a standard pulse oximeter and does not mention any AI or ML capabilities.
No
This device is a diagnostic tool that measures physiological parameters (SpO2, pulse rate, and pulse strength) for monitoring, not for treating or preventing a disease or condition.
Yes
The device measures SpO2, pulse rate, and pulse strength, which are used to assess a patient's health status, thus aiding in diagnosis.
No
The device description explicitly states it consists of a monitor and sensor in a single assembly, includes an LED display and power key, and is powered by batteries, indicating it is a hardware device with embedded software, not a software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The BCI® 3420 Digit™ Pulse Oximeter measures physiological parameters (SpO2, pulse rate, pulse strength) directly from the patient's finger. It does not analyze samples taken from the body.
- Intended Use: The intended use describes it as a "spot check device" for measuring these parameters, not for analyzing biological samples.
Therefore, the device falls under the category of a non-invasive medical device that measures physiological signs directly from the patient.
N/A
Intended Use / Indications for Use
The BCI® 3420 Digit™ Pulse Oximeter is a handheld, finger-mounted pulse oximeter that combines the monitor and sensor into one assembly that measures SpO2, pulse rate, and pulse strength. It may be used as a spot check device in the home, hospital or clinical environments, including patient ground transport in clinical and EMS (Emergency Medical Services) settings. The BCI® 3420 Digit™ Pulse Oximeter will provide reliable measurements on patients ranging from pediatric to adults.
Product codes
DQA
Device Description
The BCI® 3420 Digit™ Pulse Oximeter consists of an pulse oximeter monitor and sensor contained on a single assembly. The device includes an LED display and power on key, and is powered by two "AAA" batteries.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
finger-mounted
Indicated Patient Age Range
pediatric to adults
Intended User / Care Setting
Home, hospital or clinical environments, including patient ground transport in clinical and EMS (Emergency Medical Services) settings.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Testing of device performance included clinical testing of the SpO2 parameter and overall software validation. The results demonstrated that the BCI® 3420 Digit™ pulse oximeter performed within its specifications.
Key Metrics
Not Found
Predicate Device(s)
K943404, K980714, K942248, K001085
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
KO13/7!
Image /page/0/Picture/1 description: The image shows the logo for BCI, which is a company that specializes in battery charging and testing equipment. The logo consists of a circle with vertical lines on the left, followed by the letters BCI in bold, sans-serif font. The circle is meant to represent a battery, and the letters BCI stand for Battery Charging and Testing International.
JAN 0 3 2002
BCI, Inc. N7 W22025 Johnson Road Waukesha, WI 53186-1856 USA Tel: 262-542-3100 Fax: 262-542-3325 w.smiths-bci.com
Summary of Safety and Effectiveness
| Submitter: | BCI, Inc. |
|---|---|
| Address: | N7 W22025 Johnson Road |
| Waukesha, WI 53186 | |
| Telephone: | (262) 542-3100 |
| Contact: | VP Regulatory Affairs |
| Prepared: | September 21, 2001 |
| Proprietary Name: | BCI® 3420 Digit™ Pulse Oximeter |
| Common/Classification Name: | Pulse Oximeter |
| Predicate Devices: | BCI 3301® Hand-Held Pulse Oximeter (K943404) |
| BCI® 3401 Handheld Pulse Oximeter (K980714) | |
| Nonin® Onyx , Model 9500 (K942248, K001085) |
New Device Description:
The BCI® 3420 Digit™ Pulse Oximeter consists of an pulse oximeter monitor and sensor contained on a single assembly. The device includes an LED display and power on key, and is powered by two "AAA" batteries.
Intended Use:
The BCI® 3420 Digit™ Pulse Oximeter is a handheld, finger-mounted pulse oximeter that combines the monitor and sensor into one assembly that measures SpO2, pulse rate, and pulse strength. It may be used as a spot check device in the home, hospital or clinical environments, including patient ground transport in clinical and EMS (Emergency Medical Services) settings. The BCI® 3420 Digit™ Pulse Oximeter will provide reliable measurements on patients ranging from pediatric to adults.
1
Image /page/1/Picture/0 description: The image shows the logo for BCI, which is a company that specializes in business continuity. The logo is black and white and features a circle made of vertical lines on the left, followed by the letters BCI in bold font. There is a registered trademark symbol to the right of the I.
Performance Data:
The design of this device utilizes currently available technology found in legally marketed devices. The major difference between the new device and the predicate BCI 3301 Handheld Pulse Oximeter is the combination of the pulse oximeter monitor and sensor, similar to the Nonin® Onyx®. Testing was done to ensure that the BCI® 3420 Digit™ Pulse Oximeter would perform safely and accurately within the environment(s) for which it is to be marketed.
Safety and environmental testing was conducted in accordance with the Reviewer's Guidance for Respiratory Devices, 1993, EN 60601-1: 1990, and EN 60601-1-2: 1993. Electromagnetic compatability (EMC), electrical, mechanical durability, safety (operator and patient), and temperature/humidity testing have been completed. The results demonstrate that the BC1® 3420 Digit™ pulse oximeter is in compliance with the guidelines and standards referenced in the reviewer's guides and that it performs within its specifications and functional requirements.
Testing of device performance included clinical testing of the SpO2 parameter and overall software validation. The results demonstrated that the BCI® 3420 Digit™ pulse oximeter performed within its specifications.
The testing described above indicate that there is no functional difference between the operation of the BCI® 3420 Digit™ pulse oximeter and the predicate devices. Based on these results, it is our determination that the device is safe, effective, and performs as well as the legally marketed predicate device(s).
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
Respectfully,
Donald Alexander
Donald Alexander VP Regulatory Affairs
BCI and Digit are a BCI trademarks. The symbol ® indicates it is registered in the U.S. Patent and Trademark Office and certain other countries. Nonin and Onyx are Nonin trademarks.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized caduceus or a bird in flight, composed of three curved lines.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 0 3 2002
Donald J. Alexander Vice President of Regulatory Affairs BCI, Inc. N7 W22025 Johnson Road Waukesha, WI 53186-1856
Re: K013171
3420 Digit™ Pulse Oximeter Regulation Number: 870.2700 Regulation Name: Oximeter Regulatory Class: Class II (two) Product Code: DQA Dated: November 20, 2001 Received: November 21, 2001
Dear Mr. Alexander:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Donald J. Alexander
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely vours.
Dea G. Tell
Bram D. Zuckerman, M.D. Acting Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications For Use
510(k) Number (if Known): `K013171
Device Name: BCI® 3420 Digit™ Pulse Oximeter
Indications For Use:
Intended Use:
The BCI® 3420 Digit™ Pulse Oximeter is a handheld, finger-mounted pulse oximeter that combines the monitor and sensor into one assembly that measures SpO2, pulse rate, and pulse strength. It may be used as a spot check device in the home, hospital or clinical environments, including patient ground transport in clinical and EMS (Emergency Medical Services) settings. The BCI 3420 Digit™ Pulse Oximeter will provide reliable measurements on patients ranging from pediatric to adults.
( PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED ) ============================================================================================================================================================================
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The Counter Use
Division of Cardiovascular & Respiratory Devices
510(k) Number K013171